ARCHIVES

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial

October 13, 1995

DCPC Begins Reassessment of Year 2000 Goals; Advisors Discuss A ‘More Dynamic Model’

May 22, 1992

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011